DB
VBIV

Dmitry Balyasny’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Dmitry Balyasny’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-725
Closed -$18K – 3359
2022
Q2 		$18K Buy
+725
New +$24.7K ﹤0.01% 2501
2021
Q4 		– Sell
-29,135
Closed -$2.72M – 2666
2021
Q3 		$2.72M Buy
+29,135
New +$2.77M 0.01% 1028

Other funds holding VBIV

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.69B AUM 40.94% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Dmitry Balyasny's VBIV Position: Q3 2022 in Review

Dmitry Balyasny sold out of VBI Vaccines, Inc. New Common Stock (Canada) (VBIV) in Q3 2022, closing a stake of 725 shares — an estimated $18K sold.

Dmitry Balyasny first reported a position in VBIV in Q3 2021 and held it in 2 quarters. The position peaked at $2.72M in Q3 2021. 127 funds tracked by Wall St. Rank hold VBIV as of Q3 2022.

  • Dmitry Balyasny reported no remaining VBI Vaccines, Inc. New Common Stock (Canada) position as of Q3 2022 after selling out during the quarter.
  • Dmitry Balyasny sold 725 VBI Vaccines, Inc. New Common Stock (Canada) shares in Q3 2022, an estimated $18K.
  • Dmitry Balyasny first reported a position in VBI Vaccines, Inc. New Common Stock (Canada) in Q3 2021 and held it in 2 quarters.
  • Dmitry Balyasny's VBI Vaccines, Inc. New Common Stock (Canada) position peaked at $2.72M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held VBI Vaccines, Inc. New Common Stock (Canada) as of Q3 2022.

Based on Balyasny Asset Management's 13F filing for Q3 2022, filed 15 Nov 2022.